AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds

Artificial intelligence use cases across the federal health department spiked between fiscal years 2024 and 2025— led by a 148% year-over-year increase at the Food and Drug Administration (FDA), a |...

Roche nabs EU approval on label expansions for companion dx platform

Roche has rece | Roche received approval through the EU’s In Vitro diagnostic regulation for several label expansions of its companion diagnostic platform that can identify a cancer patient's...

Predicta links with Spanish university to offer diagnostic for blood cancers

Predicta Biosciences, a precision oncology specialist, is

Roche sticks with €600M diagnostics investment in Germany but warns of future risk

As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will not be following suit—for now. | As news hit last week that Eli Lilly and Boehri...

ADA: Dexcom CGM shows benefit in non-insulin diabetes patients

A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in a randomized trial, adding new fuel to the industry’s push to bring CGM |...

Resmed snaps up Noctrix Health in $340M sleep tech deal

Resmed has closed its $340 million acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes the sleep tech giant beyond its core sleep apnea and respiratory care busi |...

Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

Foundation Medicine tallied

Insulet issues voluntary correction for Omnipod devices in leaky insulin fault

Insulet has sent out a voluntary medical device correction notice for a series of its Omnipod devices amid a manufacturing fault that could lead to insulin leaking and not being fully delivered.

Dexcom warns of stolen glucose monitors being sold by unauthorized dealers

Dexcom warned that some lots of its G7 wearable gluc | Dexcom warned that some lots of its G7 wearable glucose monitors were stolen on their way to the scrapyard and were sold by a third-party vendor.

Olympus pushes deeper into oncology with $270M BioProtect deal

Olympus has

Medtronic inks $650M deal for SPR Therapeutics

Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose flagship product | Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose...

Endologix acquires thrombectomy system from Surmodics

Endologix, a medtech that focuses on treatments for vascular diseases, expanded its offerings with the

Labcorp joins lab results personalization push with ‘MyLabcorp’ AI app

Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial

Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease (PD) in a new proof-of-concept clinical trial. | Finnish biotech Herantis...

Lauxera Capital Partners raises a hefty €520M for health, medtech companies

Lauxera Capital Partners has nearly doubled the size of its first funding drive with a €520 million ($605 million) raise for health and medical technology companies.  | Lauxera Capital Partners has...

Ardent Health taps Fujifilm’s AI-enabled patient imaging platform

Fujifilm Healthcare Americas Corp. has signed a deal with Ardent Health to bring its enterprise imaging software to hospitals and clinics in six states. | Fujifilm Healthcare Americas Corp. has...

Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system

Acquisitive Boston Scientific is making deals again, with a major investment play into a private medtech and an option to snap up exclusive rights to its Transcatheter Aortic Valve Replacement (TAV |...

Health execs persevere in new policy landscape

Despite a prolonged period of policy uncertainty in the U.S.—and the ripple effects across the global life sciences and healthcare industries—executives at health companies are still seeing opportu |...

Why Model Medicines needs to ‘discover new colors’ in its AI drug discovery quest

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that truly deserved his investment. | “Outliers are what you're going for,” Model...

New Hepta blood test could predict GLP-1 response

While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight loss, doctors currently do not have a way to predict if a patient will successfully respond to the drugs. | While GLP-1s...